Novavax NVAX
NASDAQ NVAX
$10.14 -0.20 (-1.98%)
As of: Sep 4, 2026 · 2:36 PM EDT

Novavax (NVAX) Tax Rate (QoQ) (2010 - 2026)

Analysis

Novavax (NVAX) Tax Rate (QoQ) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Novavax 1.67 Bn 949.38 Mn 42.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 827.00
Mar 31, 2026 -1,368.00
Dec 31, 2025 178.00
Sep 30, 2025 -56.00
Jun 30, 2025 65.00
Mar 31, 2025 1,035.00
Dec 31, 2024 -1,097.00
Sep 30, 2024 -50.00
Jun 30, 2024 290.00
Mar 31, 2024 -60.00
Dec 31, 2023 -149.00
Sep 30, 2023 78.00
Jun 30, 2023 16.00
Mar 31, 2023 -163.00
Dec 31, 2022 271.00
Sep 30, 2022 -121.00
Jun 30, 2022 -157.00
Mar 31, 2022 329.00
Dec 31, 2021 -9.00
Sep 30, 2021 -89.00